Cargando…
Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials
BACKGROUND: To facilitate translational drug development for liver fibrosis, preclinical trials need to be run in parallel with clinical research. Liver function estimation by gadoxetate-enhanced dynamic contrast-enhanced MRI (DCE-MRI) is being established in clinical research, but still rarely used...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858707/ https://www.ncbi.nlm.nih.gov/pubmed/31729971 http://dx.doi.org/10.1186/s12880-019-0378-5 |
_version_ | 1783471009413726208 |
---|---|
author | Huh, Jimi Ham, Su Jung Cho, Young Chul Park, Bumwoo Kim, Bohyun Woo, Chul-Woong Choi, Yoonseok Woo, Dong-Cheol Kim, Kyung Won |
author_facet | Huh, Jimi Ham, Su Jung Cho, Young Chul Park, Bumwoo Kim, Bohyun Woo, Chul-Woong Choi, Yoonseok Woo, Dong-Cheol Kim, Kyung Won |
author_sort | Huh, Jimi |
collection | PubMed |
description | BACKGROUND: To facilitate translational drug development for liver fibrosis, preclinical trials need to be run in parallel with clinical research. Liver function estimation by gadoxetate-enhanced dynamic contrast-enhanced MRI (DCE-MRI) is being established in clinical research, but still rarely used in preclinical trials. We aimed to evaluate feasibility of DCE-MRI indices as translatable biomarkers in a liver fibrosis animal model. METHODS: Liver fibrosis was induced in Sprague-Dawley rats by thioacetamide (200 mg, 150 mg, and saline for the high-dose, low-dose, and control groups, respectively). Subsequently, DCE-MRI was performed to measure: relative liver enhancement at 3-min (RLE-3), RLE-15, initial area-under-the-curve until 3-min (iAUC-3), iAUC-15, and maximum-enhancement (Emax). The correlation coefficients between these MRI indices and the histologic collagen area, indocyanine green retention at 15-min (ICG-R15), and shear wave elastography (SWE) were calculated. Diagnostic performance to diagnose liver fibrosis was also evaluated by receiver-operating-characteristic (ROC) analysis. RESULTS: Animal model was successful in that the collagen area of the liver was the largest in the high-dose group, followed by the low-dose group and control group. The correlation between the DCE-MRI indices and collagen area was high for iAUC-15, Emax, iAUC-3, and RLE-3 but moderate for RLE-15 (r, − 0.81, − 0.81, − 0.78, − 0.80, and − 0.51, respectively). The DCE-MRI indices showed moderate correlation with ICG-R15: the highest for iAUC-15, followed by iAUC-3, RLE-3, Emax, and RLE-15 (r, − 0.65, − 0.63, − 0.62, − 0.58, and − 0.56, respectively). The correlation coefficients between DCE-MRI indices and SWE ranged from − 0.59 to − 0.28. The diagnostic accuracy of RLE-3, iAUC-3, iAUC-15, and Emax was 100% (AUROC 1.000), whereas those of RLE-15 and SWE were relatively low (AUROC 0.777, 0.848, respectively). CONCLUSION: Among the gadoxetate-enhanced DCE-MRI indices, iAUC-15 and iAUC-3 might be bidirectional translatable biomarkers between preclinical and clinical research for evaluating histopathologic liver fibrosis and physiologic liver functions in a non-invasive manner. |
format | Online Article Text |
id | pubmed-6858707 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-68587072019-11-29 Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials Huh, Jimi Ham, Su Jung Cho, Young Chul Park, Bumwoo Kim, Bohyun Woo, Chul-Woong Choi, Yoonseok Woo, Dong-Cheol Kim, Kyung Won BMC Med Imaging Research Article BACKGROUND: To facilitate translational drug development for liver fibrosis, preclinical trials need to be run in parallel with clinical research. Liver function estimation by gadoxetate-enhanced dynamic contrast-enhanced MRI (DCE-MRI) is being established in clinical research, but still rarely used in preclinical trials. We aimed to evaluate feasibility of DCE-MRI indices as translatable biomarkers in a liver fibrosis animal model. METHODS: Liver fibrosis was induced in Sprague-Dawley rats by thioacetamide (200 mg, 150 mg, and saline for the high-dose, low-dose, and control groups, respectively). Subsequently, DCE-MRI was performed to measure: relative liver enhancement at 3-min (RLE-3), RLE-15, initial area-under-the-curve until 3-min (iAUC-3), iAUC-15, and maximum-enhancement (Emax). The correlation coefficients between these MRI indices and the histologic collagen area, indocyanine green retention at 15-min (ICG-R15), and shear wave elastography (SWE) were calculated. Diagnostic performance to diagnose liver fibrosis was also evaluated by receiver-operating-characteristic (ROC) analysis. RESULTS: Animal model was successful in that the collagen area of the liver was the largest in the high-dose group, followed by the low-dose group and control group. The correlation between the DCE-MRI indices and collagen area was high for iAUC-15, Emax, iAUC-3, and RLE-3 but moderate for RLE-15 (r, − 0.81, − 0.81, − 0.78, − 0.80, and − 0.51, respectively). The DCE-MRI indices showed moderate correlation with ICG-R15: the highest for iAUC-15, followed by iAUC-3, RLE-3, Emax, and RLE-15 (r, − 0.65, − 0.63, − 0.62, − 0.58, and − 0.56, respectively). The correlation coefficients between DCE-MRI indices and SWE ranged from − 0.59 to − 0.28. The diagnostic accuracy of RLE-3, iAUC-3, iAUC-15, and Emax was 100% (AUROC 1.000), whereas those of RLE-15 and SWE were relatively low (AUROC 0.777, 0.848, respectively). CONCLUSION: Among the gadoxetate-enhanced DCE-MRI indices, iAUC-15 and iAUC-3 might be bidirectional translatable biomarkers between preclinical and clinical research for evaluating histopathologic liver fibrosis and physiologic liver functions in a non-invasive manner. BioMed Central 2019-11-15 /pmc/articles/PMC6858707/ /pubmed/31729971 http://dx.doi.org/10.1186/s12880-019-0378-5 Text en © The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Huh, Jimi Ham, Su Jung Cho, Young Chul Park, Bumwoo Kim, Bohyun Woo, Chul-Woong Choi, Yoonseok Woo, Dong-Cheol Kim, Kyung Won Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials |
title | Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials |
title_full | Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials |
title_fullStr | Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials |
title_full_unstemmed | Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials |
title_short | Gadoxetate-enhanced dynamic contrast-enhanced MRI for evaluation of liver function and liver fibrosis in preclinical trials |
title_sort | gadoxetate-enhanced dynamic contrast-enhanced mri for evaluation of liver function and liver fibrosis in preclinical trials |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858707/ https://www.ncbi.nlm.nih.gov/pubmed/31729971 http://dx.doi.org/10.1186/s12880-019-0378-5 |
work_keys_str_mv | AT huhjimi gadoxetateenhanceddynamiccontrastenhancedmriforevaluationofliverfunctionandliverfibrosisinpreclinicaltrials AT hamsujung gadoxetateenhanceddynamiccontrastenhancedmriforevaluationofliverfunctionandliverfibrosisinpreclinicaltrials AT choyoungchul gadoxetateenhanceddynamiccontrastenhancedmriforevaluationofliverfunctionandliverfibrosisinpreclinicaltrials AT parkbumwoo gadoxetateenhanceddynamiccontrastenhancedmriforevaluationofliverfunctionandliverfibrosisinpreclinicaltrials AT kimbohyun gadoxetateenhanceddynamiccontrastenhancedmriforevaluationofliverfunctionandliverfibrosisinpreclinicaltrials AT woochulwoong gadoxetateenhanceddynamiccontrastenhancedmriforevaluationofliverfunctionandliverfibrosisinpreclinicaltrials AT choiyoonseok gadoxetateenhanceddynamiccontrastenhancedmriforevaluationofliverfunctionandliverfibrosisinpreclinicaltrials AT woodongcheol gadoxetateenhanceddynamiccontrastenhancedmriforevaluationofliverfunctionandliverfibrosisinpreclinicaltrials AT kimkyungwon gadoxetateenhanceddynamiccontrastenhancedmriforevaluationofliverfunctionandliverfibrosisinpreclinicaltrials |